Skip to main content
. 2021 Sep 26;9(10):1082. doi: 10.3390/vaccines9101082

Figure 2.

Figure 2

Schematic design of PLGA encapsulated oral COVID-19 vaccine: immunogenic antigen are packaged with PLGA in the form of water-oil-water, then modified with M cell receptor-targeted peptide, targeting M cells in the small intestine and stimulating a mucosal immune response.